The Cdkn1a gene, a well-characterized transcriptional target of both Olig2 and p53 [5], encodes a cyclin-dependent kinase 2 inhibitor that mediates p53-dependent cell cycle arrest and thereby determines the fate of tumor cells under genotoxic stress [5, 6, 45, 46]. The gene discussed is TP53; the disease is neoplasm.